Position in EXEL
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$316,502
New position
Shares Held
5,817
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#507
of 751 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Stratos Wealth Advisors, LLC holds $7,912,284 across 9 Biotechnology names. EXEL ranks #4 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,630 | $5,381,150 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
16,585 | $948,993 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
7,022 | $385,788 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
5,817 | $316,502 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
5,365 | $292,607 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421 | $209,123 | |
| 7 | ABCL |
AbCellera Biologics Inc.
|
22,500 | $176,625 | |
| 8 | CADL |
Candel Therapeutics, Inc.
|
16,000 | $164,800 |
All Filings in EXEL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $316,502 | 5,817 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||